首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Evaluation of visual function and prognosis for patients with proliferative diabetic retinopathy with the low vision evaluator.
【24h】

Evaluation of visual function and prognosis for patients with proliferative diabetic retinopathy with the low vision evaluator.

机译:用低视力评估仪评估增生性糖尿病视网膜病变患者的视觉功能和预后。

获取原文
获取原文并翻译 | 示例
           

摘要

Proliferative diabetic retinopathy (PDR) is a leading cause of visual loss in adults in industrialized countries. PDR patients with light perception (LP) or hand movement (HM) acuity due to severe vitreous hemorrhage require vitreous surgery. The purpose of this study was to determine whether the visual acuity of PDR patients with LP or HM can be graded into finer steps with the Low Vision Evaluator (LoVE). In addition, we determined whether the LoVE results are correlated with the amplitude of the electroretinogram (ERG), the presence of retinal detachment (RD), or postoperative visual prognosis. The LoVE instrument is a subjective device that measures the thresholds for light stimulus and is equipped with a pair of goggles with white light-emitting diodes as the stimulus. We measured the LoVE thresholds of 19 PDR patients, whose fundi could not be observed due to vitreous hemorrhage and whose visual acuity was LP or HM. The 13 patients with HM vision had LoVE thresholds that ranged from 25.0 and 40.0dB, and the 6 patients with LP vision had LoVE thresholds that ranged from 20.0 and 40.0 dB. The LoVE thresholds of 9 patients with RD were significantly lower than those of 10 patients without RD (p < 0.001). The LoVE thresholds were correlated with the amplitude of the a- and b-waves of the ERG and the postoperative best-corrected visual acuity (BCVA) (a-wave: r = 0.70, p < 0.001; b-wave: r = 0.71, p < 0.001; postoperative BCVA: r = 0.46, p < 0.05). These results indicate that the LoVE is capable of grading the visual function of PDR patients with conventional LP and HM vision into finer steps. Thus, the LoVE is an invaluable device in predicting the postoperative visual acuity of patients with vitreous hemorrhage.
机译:增殖性糖尿病性视网膜病(PDR)是工业化国家成年人视力丧失的主要原因。因严重玻璃体出血而导致视力(LP)或手部动作(HM)敏锐的PDR患者需要进行玻璃体手术。这项研究的目的是确定是否可以使用低视力评估仪(LoVE)将LP或HM的PDR患者的视敏度分为更精细的等级。此外,我们确定LoVE结果是否与视网膜电图(ERG)的振幅,视网膜脱离(RD)的存在或术后视觉预后相关。 LoVE仪器是一种主观设备,可测量光刺激的阈值,并配有一对带有白色发光二极管作为刺激的护目镜。我们测量了19名PDR患者的LoVE阈值,这些患者由于玻璃体出血而无法观察到眼底并且其视力为LP或HM。 13例HM视力患者的LoVE阈值范围为25.0和40.0dB,6例LP视力患者的LoVE阈值范围为20.0和40.0 dB。 9例RD患者的LoVE阈值明显低于10例无RD患者的LoVE阈值(p <0.001)。 LoVE阈值与ERG的a波和b波振幅以及术后最佳矫正视力(BCVA)相关(a波:r = 0.70,p <0.001; b波:r = 0.71 ,p <0.001;术后BCVA:r = 0.46,p <0.05)。这些结果表明,LoVE能够将具有常规LP和HM视觉的PDR患者的视觉功能分级为更精细的步骤。因此,LoVE是预测玻璃体出血患者术后视敏度的宝贵工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号